Literature DB >> 23831605

Lack of the p42 form of C/EBPα leads to spontaneous immortalization and lineage infidelity of committed myeloid progenitors.

Mikkel B Schuster1, Anne-Katrine Frank, Frederik O Bagger, Nicolas Rapin, Jonas Vikesaa, Bo T Porse.   

Abstract

Acute myeloid leukemia (AML) develops via a multistep process involving several genetic and epigenetic events, which ultimately leads to the formation of a heterogeneous population of malignant cells, of which only a small subpopulation termed the leukemia initiating cell (LIC) is able to sustain the leukemia. The identity of the LIC is highly diverse and ranges from populations resembling hematopoietic stem cells or multipotent progenitors (MPPs) to more committed myeloid progenitors, and the question still remains whether this is a direct consequence of which cells are targets of the final transforming events. In this study, we use premalignant cells from a Cebpa mutant AML model, in which the LIC population resembles granulocyte-macrophage progenitors (GMPs), to show that premalignant GMPs undergo spontaneous immortalization with a high clonal frequency when cultured in vitro, suggesting that these cells constitute the target of the final transforming events. Furthermore, we show that premalignant GMPs are characterized by a distinct T cell gene expression signature correlating with an increased potential for differentiation toward the T cell lineage. These findings have implications for our understanding of the transcriptional wiring in premalignant myeloid progenitors and how this contributes to the development of AML.
Copyright © 2013 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23831605     DOI: 10.1016/j.exphem.2013.06.003

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

Review 1.  C/EBPα in normal and malignant myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2015-03-10       Impact factor: 2.490

2.  hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies.

Authors:  Miguel Gallardo; Hun Ju Lee; Xiaorui Zhang; Carlos Bueso-Ramos; Laura R Pageon; Mark McArthur; Asha Multani; Aziz Nazha; Taghi Manshouri; Jan Parker-Thornburg; Inmaculada Rapado; Alfonso Quintas-Cardama; Steven M Kornblau; Joaquin Martinez-Lopez; Sean M Post
Journal:  Cancer Cell       Date:  2015-09-24       Impact factor: 31.743

3.  Amplification of pico-scale DNA mediated by bacterial carrier DNA for small-cell-number transcription factor ChIP-seq.

Authors:  Janus S Jakobsen; Frederik O Bagger; Marie S Hasemann; Mikkel B Schuster; Anne-Katrine Frank; Johannes Waage; Kristoffer Vitting-Seerup; Bo T Porse
Journal:  BMC Genomics       Date:  2015-02-05       Impact factor: 3.969

4.  C/EBPα is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors.

Authors:  Marie S Hasemann; Felicia K B Lauridsen; Johannes Waage; Janus S Jakobsen; Anne-Katrine Frank; Mikkel B Schuster; Nicolas Rapin; Frederik O Bagger; Philipp S Hoppe; Timm Schroeder; Bo T Porse
Journal:  PLoS Genet       Date:  2014-01-09       Impact factor: 5.917

5.  The ASXL1-G643W variant accelerates the development of CEBPA mutant acute myeloid leukemia.

Authors:  Teresa D'Altri; Anna S Wilhelmson; Mikkel B Schuster; Anne Wenzel; Adrija Kalvisa; Sachin Pundhir; Anne Meldgaard Hansen; Bo T Porse
Journal:  Haematologica       Date:  2021-04-01       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.